CoreBone Raises $3.7 Million Investment to Commercialize its Bioactive Bone Graft Material for Dental and Orthopedic Treatments and Expand Activity in China

TEL AVIV, Israel, Oct. 4, 2021 -- (Healthcare Sales & Marketing Network) -- CoreBone, a company that produces bioactive, coral-based bone graft material, announced that it has completed an investment round of $3.7 million. The Guangzhou Sino-Israel Biotec... Devices, Orthopaedic, Dental, Venture Capital CoreBone, bioactive bone graft
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news